ConductScience.org, home

Trial · NCT07893808

Anesthesia and Neonatal Outcomes After Cesarean Delivery

NCT07893808, Completed, Serra Topal

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Anesthesia and Neonatal Outcomes After Cesarean Delivery. Trials, record NCT07893808. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07893808

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Anesthesia and Neonatal Outcomes After Cesarean Delivery
NCT number
NCT07893808
Status
Completed
Enrollment
21,926 participants, actual
Lead sponsor
Serra Topal
Conditions
Cesarean Delivery
Interventions
General Anesthesia (GA), Neuraxial Anesthesia (NA)
First posted
2026-10-26
Last updated
2026-10-26

Source ClinicalTrials.gov

Registered outcomes7

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryIncidence of 5-Minute Apgar Score Below 75 minutes after birth
Proportion of live-born neonates with an Apgar score below 7 at 5 minutes after birth, compared between general and neuraxial anesthesia groups and evaluated separately for elective and emergency cesarean deliveries.
SecondaryIncidence of 1-Minute Apgar Score Below 71 minute after birth
Proportion of live-born neonates with an Apgar score below 7 at 1 minute after birth, compared between general and neuraxial anesthesia groups and evaluated separately for elective and emergency cesarean deliveries.
SecondaryNICU Admission Within 24 Hours After BirthUp to 24 hours after birth
Proportion of neonates admitted to the study hospital's neonatal intensive care unit (NICU) or transferred to an external NICU within 24 hours after birth. Transfers to external NICUs were included in this outcome.
SecondaryAdmission to a Level III Neonatal Intensive Care UnitFrom birth to NICU discharge, up to 174 days
Proportion of neonates admitted to a Level III NICU during an admission initiated within 24 hours after birth. This outcome was assessed only for infants who remained at the study hospital because post-transfer information from external hospitals was unavailable.
SecondaryInvasive Ventilation During NICU AdmissionFrom birth to NICU discharge, up to 174 days
Proportion of neonates with tracheal intubation or mechanical ventilation recorded during a NICU admission that began within 24 hours after birth. This outcome was assessed only for infants who remained at the study hospital. The timing of ventilation within the admission was not recorded.
SecondaryNon-Invasive Ventilation During NICU AdmissionFrom birth to NICU discharge, up to 174 days
Proportion of neonates receiving non-invasive ventilation during a NICU admission that began within 24 hours after birth. Only infants who remained at the study hospital were included because post-transfer information was unavailable. The timing of ventilation within the admission was not recorded.
SecondaryLength of Neonatal Intensive Care Unit StayFrom birth to NICU discharge, up to 174 days
Duration of NICU stay, measured in days, among neonates admitted to the study hospital's NICU. Infants transferred to external hospitals were excluded because complete post-transfer hospitalization data were unavailable.

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers0

The papers the trial lists on ClinicalTrials.gov.

None in this release.

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT07893808

GET https://conductscience.org/api/trials/v1/NCT07893808/registered